IHT Wealth Management’s United Therapeutics UTHR Stock Holding History

IHT Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-31	Closed	-$4K	–	1322
2016 Q4	$4K	Buy	+31	New	+$3.96K	﹤0.01%	960

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IHT Wealth Management's UTHR Position: Q1 2017 in Review

IHT Wealth Management sold out of United Therapeutics (UTHR) in Q1 2017, closing a stake of 31 shares — an estimated $4K sold.

IHT Wealth Management first reported a position in UTHR in Q4 2016 and held it in 1 quarter. The position peaked at $4K in Q4 2016. 411 funds tracked by Wall St. Rank hold UTHR as of Q1 2017.

IHT Wealth Management reported no remaining United Therapeutics position as of Q1 2017 after selling out during the quarter.
IHT Wealth Management sold 31 United Therapeutics shares in Q1 2017, an estimated $4K.
IHT Wealth Management first reported a position in United Therapeutics in Q4 2016 and held it in 1 quarter.
IHT Wealth Management's United Therapeutics position peaked at $4K in Q4 2016.
411 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2017.

Based on IHT Wealth Management's 13F filing for Q1 2017, filed 16 May 2017.